CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- SC TO-C Deal Written Communication Relating to an Issuer
- 8-K/A Event Material agreement · Regulation FD disclosure
- SC TO-C Deal Written Communication Relating to an Issuer
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Grant or award EVP, G R&D and CMO acquired 26,577 shares (grant or award)
- 4 Grant or award SVP, Technical Operations acquired 9,244 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 17,719 shares (grant or award)
- 4 Grant or award President & COO acquired 34,666 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 23,111 shares (grant or award)
- 4 Open-market sale SVP, Chief Accounting Officer sold 5,586 shares at an average $144.26 ($805,842)
- 4 Open-market sale EVP & Chief Legal Officer sold 3,800 shares at $144.87 ($550,506)
- 4 Planned sale Chairman & CEO sold 6,500 shares at $144.25 ($937,625)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Chairman & CEO sold 1,500 shares at $122.31 ($183,465)
Page 14 of 110 · 2,194 filings